Skip to main content
search

Market Access & Commercial

Sign up

Latest resources

Featured resource

Latest market access & commercial blogs

Meet our experts at the following events

Conference

DIA RSIDM 2026

February 2 - 4, 2026 – Bethesda North Marriott Hotel & Conference Center, North Bethesda, MD – Booth 202

All market access & commercial resources

Supporting KalVista’s NDA Submission for a Novel HAE Treatment​

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Case Study

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Certara Services, Drug Development, Webinar

Best Practices for AI Prompt Engineering in Life Sciences in 2025

Certara Products, Certara.AI, Blog

From Cost Center to Value Driver: Making the Case for Total Value of Ownership (TVO) in Life Sciences

Certara Products - BaseCase, Blog

U.S. International Reference Pricing: Global Implications and Pharma Strategy

Certara Services, Market Access, Blog

Essentials of Model-informed Drug Development in Oncology

Certara Products - Simcyp, Modeling and Simulation - PBPK, Pharmacometrics, Quantitive Systems Pharmacology (QSP), Blog

Preparing for the Operational Burden of OS Requirements in Oncology Trials

Certara Services, Oncology/Hematology, Press Coverage, Video

How RWE and Predictive Modeling Support OS-Focused Trial Designs

Certara Services, Oncology/Hematology, Press Coverage, Video

Using Model-Informed Drug Development to Support OS Endpoints

Certara Services, Oncology/Hematology, Press Coverage, Video

How FDA’s Focus on Overall Survival Redefines Trial Success

Certara Services, Oncology/Hematology, Press Coverage, Video

Operational Challenges of Using Overall Survival as a Primary Endpoint

Certara Services, Oncology/Hematology, Press Coverage, Video

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Biologics, Cell and Gene Therapy, Certara Services, Therapeutic Specialties, Press Coverage
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.